Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of GSK232802 in postmenopausal women with vasomotor symptoms
2007-001295-36Phase 2Completed
- Sponsor
- GSK
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK232802 in vasomotor symptoms (3 arms), sponsored by GSK. Primary endpoints: Safety and tolerability, Endometrial safety and 2 more. Started May 2007; status: completed.
02
Drugs
GSK232802
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on 2007-001295-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001295-36.